Lipella Pharmaceuticals (NASDAQ:LIPO) Trading Up 22.9% – Time to Buy?

Lipella Pharmaceuticals Inc. (NASDAQ:LIPO)’s stock price was up 22.9% during trading on Friday . The stock traded as high as $0.2150 and last traded at $0.2150. Approximately 1,226 shares changed hands during trading, a decline of 70% from the average daily volume of 4,136 shares. The stock had previously closed at $0.1750.

Lipella Pharmaceuticals Trading Up 22.9%

The business’s fifty day simple moving average is $0.29 and its 200 day simple moving average is $0.50. The stock has a market cap of $993,515.00, a price-to-earnings ratio of -0.05 and a beta of 0.14.

Lipella Pharmaceuticals Company Profile

Lipella Pharmaceuticals Inc, a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD).